Objective sleep parameters and diurnal blood pressure in concurrent hypertension and type 2 diabetes
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Hypertension is a primary cardiovascular complication in type 2 diabetes, with a significantly increased risk of morbidity and mortality compared to the general population. Ambulatory blood pressure monitoring is essential because blood pressure exhibits circadian rhythmicity, and sleep plays a crucial role in modulating nocturnal blood pressure patterns and overall cardiovascular risk.
Method
A total of 20 patients (63.75 ± 4.44 years old, 40% female, duration of T2D: 12.3 ± 6.24 years) underwent ambulatory blood pressure monitoring (ABPM) and actigraphy in a free-living condition. Multi-day sleep parameters including total sleep time, sleep efficiency, wake after sleep onset, sleep onset latency and number of awakenings were assessed by wrist actigraphy supplemented with sleep diary, ABPM was measured for 24 hours during the sleep assessment period. Associations between parameters and ABPM across total sleep measurement period and the exact date of ABPM measurement were investigated, respectively.
Results
Sleep onset latency was associated with 24-hour coefficient of variance of systolic blood pressure (β-coefficient: 0.323, 95% CI: [0.014, 0.632], p = 0.04). Inter-day sleep efficiency was inversely associated with SD and CV (SD: β-coefficient: -0.373, 95% CI: [-0.676, -0.071], P = 0.02; CV: β-coefficient: -0.588, 95% CI: [-1.141, -0.036], P = 0.04) of diastolic blood pressure.
Conclusion
In individuals with T2D and hypertension, both acute and chronic sleep disturbances, particularly prolonged sleep onset latency and reduced multi-day sleep efficiency, are closely associated with increased blood pressure variability, highlighting the importance of sleep quality in cardiovascular risk management.
